Drawing for STAND UP TO CANCER CATALYST

USPTO serial 87089186

STAND UP TO CANCER CATALYST

Reviewed by CopyMark Law Group

Reg. 5150268Status 701Renewal
Filing date
Status date
Registration date
Feb 28, 2017
Examiner
BODRI, KRISTIN MARIE
Law office
TMEG LAW OFFICE 105

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with STAND UP TO CANCER CATALYST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Price

Andrew D. Price Venable LLPP.O. Box 34385Washington, DC 20043-9998United States

Goods and services

ClassDescriptionStatusFirst use
035Administration and management of research grants relating to cancer treatment and diagnosisACTIVEJun 21, 2016
042Medical and scientific research in the field of cancer treatment and diagnosisACTIVEJun 21, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 28, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 30, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Nov 30, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Nov 30, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 26, 2023ES8RTEAS SECTION 8 RECEIVED—
Feb 28, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 23, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 23, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 28, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 11, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Oct 11, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 11, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 11, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 11, 2016DOCKASSIGNED TO EXAMINER—
Jul 6, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 5, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance